Impact of the COVID-19 Pandemic on Patterns of Prescription Opioid Use: A Retrospective Cohort Study of Adults Without a Cancer Diagnosis Initiating Opioids Using Administrative Claims Data.
Anne-Marie CastillouxGenaro CastillonYola MoridePublished in: Drugs - real world outcomes (2022)
Our findings showed that the COVID-19 lockdown had an impact on initial number of days' supply, which is a risk factor for long-term use and ultimately opioid-related harm. However, over time, prescription practices and use reverted to those observed in the pre-pandemic period.
Keyphrases
- coronavirus disease
- sars cov
- chronic pain
- pain management
- papillary thyroid
- healthcare
- primary care
- health insurance
- squamous cell
- respiratory syndrome coronavirus
- electronic health record
- big data
- childhood cancer
- lymph node metastasis
- squamous cell carcinoma
- data analysis
- drug induced
- young adults
- artificial intelligence